• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类癌症中miR-1908的失调

miR-1908 Dysregulation in Human Cancers.

作者信息

Shen Jinze, Wu Yuchen, Ruan Wenjing, Zhu Feng, Duan Shiwei

机构信息

Department of Clinical Medicine, Zhejiang University City College School of Medicine, Hangzhou, China.

Department of Clinical Medicine, The First School of Medicine, Wenzhou Medical University, Wenzhou, China.

出版信息

Front Oncol. 2022 Apr 7;12:857743. doi: 10.3389/fonc.2022.857743. eCollection 2022.

DOI:10.3389/fonc.2022.857743
PMID:35463352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9021824/
Abstract

MiR-1908 is a miRNA located in the intron of the fatty acid desaturase 1 (FADS1) gene. The expression level of miR-1908 is abnormal in many diseases such as cancer. miR-1908 can inhibit the expression of at least 27 target genes by binding to the 3' untranslated region (3' UTR) of target genes. miR-1908 is involved in the biological processes of cell proliferation, cell differentiation, cell apoptosis, cancer cell invasion, and metastasis. The expression of miR-1908 is regulated by 11 factors, including lncRNA HOTTIP, adipokines (TNF-α, leptin, and resistin), NF-κB, free fatty acid (FFA), cholesterol, stearoyl-CoA desaturase (SCD1), immune-related transcription factors (STAT1, RB1, and IRF1). The expression of miR-1908 is also affected by the anticancer drug OSW-1, growth hormone (GH), and the anticonvulsant drug sodium valproate. In addition, the aberrant expression of miR-1908 is also related to the prognosis of a variety of cancers, including non-small cell lung cancer (NSCLC), ovarian cancer (OC), breast cancer, cervical cancer, glioma, high-grade serous ovarian carcinoma (HGSOC), osteosarcoma, etc. This article summarizes the abnormal expression pattern of miR-1908 in various diseases and its molecular regulation mechanisms. Our work will provide potential hints and direction for future miR-1908-related research.

摘要

MiR-1908是一种位于脂肪酸去饱和酶1(FADS1)基因内含子中的微小RNA。在许多疾病如癌症中,MiR-1908的表达水平异常。MiR-1908可通过与靶基因的3'非翻译区(3'UTR)结合来抑制至少27个靶基因的表达。MiR-1908参与细胞增殖、细胞分化、细胞凋亡、癌细胞侵袭和转移等生物学过程。MiR-1908的表达受11种因素调控,包括长链非编码RNA HOTTIP、脂肪因子(肿瘤坏死因子-α、瘦素和抵抗素)、核因子-κB、游离脂肪酸(FFA)、胆固醇、硬脂酰辅酶A去饱和酶(SCD1)、免疫相关转录因子(信号转导和转录激活因子1、视网膜母细胞瘤蛋白1和干扰素调节因子1)。MiR-1908的表达还受抗癌药物OSW-1、生长激素(GH)和抗惊厥药物丙戊酸钠的影响。此外,MiR-1908的异常表达还与多种癌症的预后相关,包括非小细胞肺癌(NSCLC)、卵巢癌(OC)、乳腺癌、宫颈癌、神经胶质瘤、高级别浆液性卵巢癌(HGSOC)、骨肉瘤等。本文总结了MiR-1908在各种疾病中的异常表达模式及其分子调控机制。我们的工作将为未来与MiR-1908相关的研究提供潜在的线索和方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd5/9021824/e6762996ccee/fonc-12-857743-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd5/9021824/f827c3bab4c7/fonc-12-857743-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd5/9021824/1c372a0c83e6/fonc-12-857743-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd5/9021824/6308d709d400/fonc-12-857743-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd5/9021824/938b5ae83a84/fonc-12-857743-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd5/9021824/2655e1858c5a/fonc-12-857743-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd5/9021824/b4acda5dd49c/fonc-12-857743-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd5/9021824/e6762996ccee/fonc-12-857743-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd5/9021824/f827c3bab4c7/fonc-12-857743-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd5/9021824/1c372a0c83e6/fonc-12-857743-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd5/9021824/6308d709d400/fonc-12-857743-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd5/9021824/938b5ae83a84/fonc-12-857743-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd5/9021824/2655e1858c5a/fonc-12-857743-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd5/9021824/b4acda5dd49c/fonc-12-857743-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd5/9021824/e6762996ccee/fonc-12-857743-g007.jpg

相似文献

1
miR-1908 Dysregulation in Human Cancers.人类癌症中miR-1908的失调
Front Oncol. 2022 Apr 7;12:857743. doi: 10.3389/fonc.2022.857743. eCollection 2022.
2
Novel Insights into miR-944 in Cancer.对癌症中miR-944的全新见解。
Cancers (Basel). 2022 Aug 31;14(17):4232. doi: 10.3390/cancers14174232.
3
Aberrant Expression of miR-1301 in Human Cancer.miR-1301在人类癌症中的异常表达。
Front Oncol. 2022 Jan 5;11:789626. doi: 10.3389/fonc.2021.789626. eCollection 2021.
4
MiR-212-3p suppresses high-grade serous ovarian cancer progression by directly targeting MAP3K3.微小RNA-212-3p通过直接靶向丝裂原活化蛋白激酶激酶激酶3抑制高级别浆液性卵巢癌进展。
Am J Transl Res. 2020 Mar 15;12(3):875-888. eCollection 2020.
5
MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer.miR-661 通过直接抑制非小细胞肺癌中的 RB1 促进肿瘤侵袭和转移。
Mol Cancer. 2017 Jul 17;16(1):122. doi: 10.1186/s12943-017-0698-4.
6
Regulation of the MIR155 host gene in physiological and pathological processes.miR-155 宿主基因在生理和病理过程中的调控。
Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14.
7
MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer.miR-585-3p 通过直接靶向 CAPN9 抑制高级别浆液性卵巢癌中的肿瘤增殖和迁移。
J Ovarian Res. 2021 Jul 8;14(1):90. doi: 10.1186/s13048-021-00841-w.
8
MicroRNA-625-3p improved proliferation and involved chemotherapy resistance via targeting PTEN in high grade ovarian serous carcinoma.微小 RNA-625-3p 通过靶向 PTEN 改善高级别卵巢浆液性癌的增殖并涉及化疗耐药性。
J Ovarian Res. 2022 Jan 14;15(1):7. doi: 10.1186/s13048-021-00939-1.
9
Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target.miRNA-330 在癌症中的失调表达和功能:一个潜在的治疗靶点。
Biomed Pharmacother. 2022 Feb;146:112600. doi: 10.1016/j.biopha.2021.112600. Epub 2021 Dec 27.
10
Good or not good: Role of miR-18a in cancer biology.好坏与否:miR-18a在癌症生物学中的作用
Rep Pract Oncol Radiother. 2020 Sep-Oct;25(5):808-819. doi: 10.1016/j.rpor.2020.07.006. Epub 2020 Aug 12.

引用本文的文献

1
Ubiquitination in lipid metabolism reprogramming: implications for pediatric solid tumors.脂质代谢重编程中的泛素化:对小儿实体瘤的影响
Front Immunol. 2025 Apr 30;16:1554311. doi: 10.3389/fimmu.2025.1554311. eCollection 2025.
2
A Novel Insight into the Role of Obesity-Related Adipokines in Ovarian Cancer-State-of-the-Art Review and Future Perspectives.肥胖相关脂肪因子在卵巢癌中作用的新见解——最新综述与未来展望
Int J Mol Sci. 2025 Feb 21;26(5):1857. doi: 10.3390/ijms26051857.
3
miRNA and leptin signaling in metabolic diseases and at extreme environments.

本文引用的文献

1
miR1908-5p regulates energy homeostasis in hepatocyte models.miR1908-5p 调控肝细胞模型中的能量稳态。
Sci Rep. 2021 Dec 9;11(1):23748. doi: 10.1038/s41598-021-03156-4.
2
LncRNA HOTTIP from synovial fibroblast-derived exosomes: A novel molecular target for rheumatoid arthritis through the miR-1908-5p/STAT3 axis.滑膜成纤维细胞来源的外泌体中的长链非编码 RNA HOTTIP:通过 miR-1908-5p/STAT3 轴治疗类风湿关节炎的新分子靶点。
Exp Cell Res. 2021 Dec 15;409(2):112943. doi: 10.1016/j.yexcr.2021.112943. Epub 2021 Nov 19.
3
Extracellular microRNA profiling for prognostic prediction in patients with high-grade serous ovarian carcinoma.
微小RNA与瘦素信号通路在代谢性疾病及极端环境中的作用
Pharmacol Res Perspect. 2024 Aug;12(4):e1248. doi: 10.1002/prp2.1248.
4
Topology and Dynamics of Transcriptome (Dys)Regulation.转录组(失调)调控的拓扑和动力学。
Int J Mol Sci. 2024 May 2;25(9):4971. doi: 10.3390/ijms25094971.
5
A novel TCGA-validated programmed cell-death-related signature of ovarian cancer.一种经TCGA验证的卵巢癌程序性细胞死亡相关特征。
BMC Cancer. 2024 Apr 23;24(1):515. doi: 10.1186/s12885-024-12245-2.
6
Effect of traditional Chinese medicine in osteosarcoma: Cross-interference of signaling pathways and potential therapeutic targets.中药在骨肉瘤中的作用:信号通路的交叉干扰和潜在的治疗靶点。
Medicine (Baltimore). 2024 Jan 19;103(3):e36467. doi: 10.1097/MD.0000000000036467.
7
tRNA-derived fragments: mechanism of gene regulation and clinical application in lung cancer.tRNA 衍生片段:基因调控机制及在肺癌中的临床应用。
Cell Oncol (Dordr). 2024 Feb;47(1):37-54. doi: 10.1007/s13402-023-00864-z. Epub 2023 Aug 29.
8
RNA atlas and competing endogenous RNA regulation in tissue-derived exosomes from luminal B and triple-negative breast cancer patients.管腔B型和三阴性乳腺癌患者组织来源外泌体中的RNA图谱及竞争性内源性RNA调控
Front Oncol. 2023 Jul 7;13:1113115. doi: 10.3389/fonc.2023.1113115. eCollection 2023.
9
The tumor suppressor role and ceRNA network of miR-1294 in cancer.miR-1294 在癌症中的肿瘤抑制作用和 ceRNA 网络。
Oncol Res. 2023 Mar 1;31(1):1-12. doi: 10.32604/or.2022.027359. eCollection 2023.
10
Fatty acid metabolism: A new therapeutic target for cervical cancer.脂肪酸代谢:宫颈癌的一个新治疗靶点。
Front Oncol. 2023 Mar 28;13:1111778. doi: 10.3389/fonc.2023.1111778. eCollection 2023.
高级别浆液性卵巢癌患者预后预测的细胞外 microRNA 分析。
Cancer Sci. 2021 Dec;112(12):4977-4986. doi: 10.1111/cas.15154. Epub 2021 Oct 19.
4
Circulating miR-19b-3p as a Novel Prognostic Biomarker for Acute Heart Failure.循环 miR-19b-3p 作为急性心力衰竭的新型预后生物标志物。
J Am Heart Assoc. 2021 Oct 19;10(20):e022304. doi: 10.1161/JAHA.121.022304. Epub 2021 Oct 6.
5
miR-940 is a new biomarker with tumor diagnostic and prognostic value.微小RNA-940是一种具有肿瘤诊断和预后价值的新型生物标志物。
Mol Ther Nucleic Acids. 2021 May 8;25:53-66. doi: 10.1016/j.omtn.2021.05.003. eCollection 2021 Sep 3.
6
A Common Polymorphism in the Locus Links miR1908 to Low-Density Lipoprotein Cholesterol Through BMP1.一个常见的 Locus 多态性通过 BMP1 将 miR1908 与低密度脂蛋白胆固醇联系起来。
Arterioscler Thromb Vasc Biol. 2021 Aug;41(8):2252-2262. doi: 10.1161/ATVBAHA.121.316473. Epub 2021 Jun 17.
7
miR-34a inhibits melanoma growth by targeting ZEB1.miR-34a 通过靶向 ZEB1 抑制黑色素瘤生长。
Aging (Albany NY). 2021 Jun 8;13(11):15538-15547. doi: 10.18632/aging.203114.
8
Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives.癌症中靶向BCL-2:进展、挑战与展望
Cancers (Basel). 2021 Mar 14;13(6):1292. doi: 10.3390/cancers13061292.
9
Circulating plasma exosomal miRNA profiles serve as potential metastasis-related biomarkers for hepatocellular carcinoma.循环血浆外泌体微小RNA谱作为肝细胞癌潜在的转移相关生物标志物。
Oncol Lett. 2021 Feb;21(2):168. doi: 10.3892/ol.2021.12429. Epub 2021 Jan 4.
10
Oncogenic miRNA-1908 targets HDAC10 and promotes the aggressive phenotype of cervical cancer cell.致癌 miRNA-1908 靶向 HDAC10 并促进宫颈癌细胞的侵袭表型。
Kaohsiung J Med Sci. 2021 May;37(5):402-410. doi: 10.1002/kjm2.12348. Epub 2021 Jan 25.